ZNF350 gene polymorphisms promote the response to Peg-IFNα therapy through JAK-STAT signaling pathway in patients with chronic hepatitis B

BackgroundThe varying individual responses to Pegylated interferon-α (Peg-IFNα) in patients with chronic hepatitis B (CHB) pose significant hurdles in treatment optimization, and the underlying mechanisms remain unclear.ObjectiveWe aimed to identify genetic polymorphisms influencing the efficacy of...

Descripció completa

Dades bibliogràfiques

Autors principals:	Jianhui Guo, Shaoying Guo, Tianbin Chen, Yongbin Zeng, Ya Fu, Qishui Ou
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2024-11-01
Col·lecció:	Frontiers in Immunology
Matèries:	hepatitis B virus single nucleotide polymorphism zinc finger protein 350 Peg-IFNα therapeutic effect
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1488055/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!